Serving Size: 1 Capsule
Each Capsule Contains:
(as Ferrous Asparto Glycinate -Sumalate® and Ferrous Bis-Glycinate Chelate - Ferrochel® and ferrous fumarate
(as Ascorbic Acid)
(as ((6S)-N5-methyltetrahydrofolic acid calcium salt (molar equivalent to 600 mcg of Folic acid) (Folic acid, USP 400 mcg)
(as Cupric Oxide)
DESCRIPTION: FeRivaFA® is a prescription iron supplement. FeRivaFA® is a red gel capsule.
OTHER INGREDIENTS: Silicon dioxide and magnesium stearate. Gel capsule: (bovine gelatin, titanium dioxide, FD&C blue #1 and FD&C red #40).
INDICATIONS: FeRivaFA® is a multivitamin/multimineral dietary supplement indicated for use in improving the nutritional status of patients with iron deficiency.
CONTRAINDICATIONS: FeRivaFA® is is contraindicated in patients with a known hypersensitivity to any of the ingredients. Hemochromatosis and hemosiderosis are contraindicated to iron therapy.
PRECAUTIONS: Folic acid alone is improper therapy in the treatment of pernicious anemia and other megaloblastic anemia where Vitamin B12 is deficient. Folic acid in doses above 1.0 mg daily may obscure pernicious anemia in that hematologic remission can occur while neurological manifestations progress. While prescribing this nutritional supplement for pregnant women, nursing mothers or for women prior to conception, their medical condition and other drugs, herbs and/or supplements consumption should be considered.
PEDIATRIC USE: Safety and effectiveness have not been studied in pediatric patients.
ADVERSE REACTIONS: Allergic sensitization has been reported following both oral and parenteral administration of folic acid.
DOSAGE AND ADMINISTRATION: Adults, one (1) capsule daily, with or without food, or as prescribed by your healthcare provider. Do not administer to children under the age of 12.
HOW SUPPLIED: In child-resistant bottles of 30 capsules (75854-319-30). The listed product number is not a National Drug Code, but has instead been formatted to comply with standard industry practice for pharmacy computer systems.
STORAGE: Store between 20°- 25°C (68°- 77°F) excursions permitted to 15°- 30°C (59°- 86°F). [See USP Controlled Room Temperature.]
Ferrochel® is a registered trademark of Albion Laboratories, Inc. covered by U.S. Patents 6,716,814 & 7,838,042.
Sumalate® is a registered trademark of Albion Laboratories,Inc., covered by one or more claims of U.S. Patent Nos. 6,716,814; 8,007,846; and 8,425,956.